Dynamic Toll-like receptor expression predicts outcome of sclerotherapy for lymphatic malformations with OK-432 in children
Autor: | Marc Reismann, Ola Winqvist, Josephine Radtke, Tomas Wester, Nader Ghaffarpour, Ethel Luvall, Adan Chari Jirmo, Gösta Claesson |
---|---|
Rok vydání: | 2013 |
Předmět: |
Lipopolysaccharides
Male medicine.medical_specialty Pathology medicine.medical_treatment Stimulation Antineoplastic Agents Biology Ligands Gastroenterology Monocytes Picibanil Downregulation and upregulation Predictive Value of Tests Statistical significance Internal medicine Sclerotherapy medicine Humans Involution (medicine) Lymphatic malformations Toll-like receptor Lymphatic Abnormalities Infant Flow Cytometry Up-Regulation Toll-Like Receptor 4 Toll-Like Receptor 7 Child Preschool TLR4 Surgery Female Drug Monitoring |
Zdroj: | The Journal of surgical research. 187(1) |
ISSN: | 1095-8673 |
Popis: | Sclerotherapy with OK-432 is recommended as a first-line treatment for lymphatic malformations. However, 40% of patients show poor response, defined by involution to50% of the original size. It has been suggested that the OK-432 effect is highly dependent on the Toll-like receptor (TLR) 4-dependent expression of TLR7 in antigen-presenting cells. We hypothesized that the ability for TLR expression in monocytes after treatment with the TLR4-ligand lipopolysaccharide (LPS) can be used to predict successful OK-432 treatment.Blood was taken from children with low responder (LR, n = 6) and high responder (HR, n = 5) of previous OK-432 treatment. Monocytes were stimulated with LPS for 20 h. TLR expression was analyzed with fluorescence-activated cell sorting (mean fluorescence intensity). The level of significance was P ≤ 0.05.The mean age of patients in the HR group was 1.4 ± 0.9 y and in the LR group 2.8 ± 2.9 y (P = 0.31). The mean TLR4 upregulation after LPS stimulation in the HR group was significantly higher than in the LR group (factor 3.6 versus factor 1 compared with nonstimulated controls; P = 0.037). The mean TLR7 expression did not show significant differences between the groups.Dynamic TLR4 expression represents most probably a predictive parameter for the treatment of lymphatic malformations with OK-432 and should be further investigated. |
Databáze: | OpenAIRE |
Externí odkaz: |